A mechanism-based prognostic enrichment strategy for the development of the TREM-1 inhibitor nangibotide in septic shock
Bruno François(Inserm), Derek C. Angus(University of Pittsburgh), Mitchell M. Levy(Brown University), Ricard Ferrer(Universitat Autònoma de Barcelona), Pierre-François Laterre(UCLouvain)
Cited by 5
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k